- Profile
- Personal Information
- Publications
Experts in Nephrology
Jessy J. Alexander Ibrahim Batal Ann Hagan Tanya Hoodbhoy Luis Alfredo Bent-Shaw Stephen Y Nakada Wade A Bushman David F Jarrard Patrick H McKenna David R Paolone Daniel H Williams IV E. Jason Abel Jyotsna Bhatnagar Sara Best Dale E Bjorling Reginald C Bruskewitz Tracy M Downs Andrew K Graf Dan R. Gralnek Sean P Hedican View MoreBiography
Mr Kutay was first elected to the Board of Novo Nordisk A/S in March 2017. His term as a board member expires in March 2018. In March 2017, the Board of Directors of Novo Nordisk A/S assessed that Mr Kutay is not regarded as an independent board member as defined in Section 3.2.1 of the Danish Recommendations on Corporate Governance designated by Nasdaq Copenhagen due to Mr Kutay being the chief executive officer of Novo Holdings A/S. Mr Kutay became a member of the Nomination Committee and the Remuneration Committee at Novo Nordisk A/S in March 2017.
Research Intrest
Pharmaceutical, biotechnology